Human LY75/CD205 Protein (LY7-HM105)

  • Express System: Expi293
  • Product Tag: C-His
  • Purity: > 95% as determined by Tris-Bis PAGE; > 95% as determined by HPLC
  • Activity: Immobilized Human LY75, His Tag at 0.1μg/ml (100μl/well) on the plate. Dose response curve for Anti-LY75 Antibody, hFc Tag with the EC50 of 8ng/ml determined by ELISA. See testing image for detail.
  • Exact Sequence: Ser28-Asp1666

Catalog: LY7-HM105

$375.00
Size:

Order now get it on

Product Description Recombinant Human LY75/CD205 Protein is expressed from Expi293 with His tag at the C-terminal.; It contains Ser28-Asp1666.
Product Category Recombinant Protein
Target LY75/CD205
Synonyms Ly-75; DEC-205; CD205; CLEC13B; GP200-MR6
Gene/Protein ID O60449-1
Species Human
Exact Sequence Ser28-Asp1666
Molecular Weight The protein has a predicted MW of 190.2 kDa. Due to glycosylation, the protein migrates to 230-245 kDa based on Tris-Bis PAGE result.
Activity Immobilized Human LY75, His Tag at 0.1μg/ml (100μl/well) on the plate. Dose response curve for Anti-LY75 Antibody, hFc Tag with the EC50 of 8ng/ml determined by ELISA. See testing image for detail.
Product Tag C-His
Express System Expi293
Purity > 95% as determined by Tris-Bis PAGE; > 95% as determined by HPLC
Endotoxin Less than 1EU per ug by the LAL method.
Form Liquid
Shipping Shipped with blue ice or dry ice.
Formulation Supplied as 0.22μm filtered solution in PBS (pH 7.4). Please dilute to the desired concentration according to the concentration of the solution shown on the product label.
Stability And Storage Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
Immobilized Human LY75, His Tag at 0.1μg/ml (100μl/well) on the plate. Dose response curve for Anti-LY75 Antibody, hFc Tag with the EC50 of 8ng/ml determined by ELISA.
The purity of Human LY75 is greater than 95% as determined by SEC-HPLC.
Human LY75 on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.

You may also be interested in